Literature DB >> 8033117

Absence of N-ras mutations in myeloid and lymphoid blast crisis of chronic myeloid leukemia.

F Watzinger1, A Gaiger, H Karlic, R Becher, K Pillwein, T Lion.   

Abstract

Mutations within N-ras oncogene codons 12, 13, and 61 occur in approximately 25-30% of patients with acute nonlymphocytic leukemia and at a lower frequency (6-20%) in patients with acute lymphocytic leukemia. Moreover, N-ras mutations have been described in patients with chronic myeloid leukemia (CML) in blast crisis but have not been observed during the chronic phase of the disease. In view of the morphological and clinical similarities between acute leukemia and the blast crisis of CML, the question was raised whether the presence of N-ras mutations is associated with the phenotype of acute leukemia. We investigated leukemic cells from 100 patients with CML for the presence of N-ras mutations in the mutational hot spot codons. The cases analyzed included 87 diagnosed with different types of blast crisis and 13 cases in accelerated or chronic phase of the disease. Fragments from N-ras exons I and II containing the codons of interest were amplified by polymerase chain reaction and analyzed for the presence of point mutations by three different technical approaches, including specific oligonucleotide hybridization, direct sequencing, and single-strand conformation polymorphism analysis. N-ras mutations were not detected in any of the CML patients investigated. Only one patient, in whom the initial diagnosis of CML-blast crisis had been revised to chronic myelomonocytic leukemia, displayed an N-ras mutation within codon 13. Our data strongly suggest that N-ras mutations do not play a role in myeloid or lymphoid blast crisis of CML.

Entities:  

Mesh:

Year:  1994        PMID: 8033117

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  High sequence similarity within ras exons 1 and 2 in different mammalian species and phylogenetic divergence of the ras gene family.

Authors:  F Watzinger; B Mayr; E Haring; T Lion
Journal:  Mamm Genome       Date:  1998-03       Impact factor: 2.957

Review 2.  Behavioral genetics of the depression/cancer correlation: a look at the Ras oncogene family and the 'cerebral diabetes paradigm'.

Authors:  Janet K Brewer
Journal:  J Mol Neurosci       Date:  2008-06-18       Impact factor: 3.444

Review 3.  Biology of chronic myeloid leukemia and possible therapeutic approaches to imatinib-resistant disease.

Authors:  Chikashi Yoshida; Junia V Melo
Journal:  Int J Hematol       Date:  2004-06       Impact factor: 2.490

4.  Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 Patients.

Authors:  Klaus Geissler; Eva Jäger; Agnes Barna; Michael Gurbisz; Temeida Graf; Elmir Graf; Thomas Nösslinger; Michael Pfeilstöcker; Heinz Tüchler; Thamer Sliwa; Felix Keil; Christoph Geissler; Sonja Heibl; Josef Thaler; Sigrid Machherndl-Spandl; Otto Zach; Ansgar Weltermann; Peter Bettelheim; Reinhard Stauder; Armin Zebisch; Heinz Sill; Ilse Schwarzinger; Bruno Schneeweiss; Leopold Öhler; Ernst Ulsperger; Rajko Kusec; Ulrich Germing; Wolfgang R Sperr; Paul Knöbl; Ulrich Jäger; Gregor Hörmann; Peter Valent
Journal:  Int J Mol Sci       Date:  2020-04-24       Impact factor: 5.923

5.  Chronic myeloid leukemia extramedullary blast crisis presenting as central nervous system leukemia: A case report.

Authors:  Mingwei Jin; Chengmin Xuan; Jizhao Gao; Rui Han; Shumei Xu; Lei Wang; Yuan Wang; Kunpeng Shi; Sunil Rauniyar; Qi An
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

Review 6.  The microRNAs involved in human myeloid differentiation and myelogenous/myeloblastic leukemia.

Authors:  Xiao-Shuang Wang; Jun-Wu Zhang
Journal:  J Cell Mol Med       Date:  2008-06-28       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.